Skip to main content

Tweets

Best Rheumatologists (7.19.2024) Dr. Jack Cush reviews the news and journal reports of interesting, including irAE, pollution and Psoriasis, microwave therapy, scleroderma without scleroderma that only the best rheumatologists could discern. https://t.co/2Tkdat6CXv https://t.co/1lOfbgNZvn
Dr. John Cush @RheumNow ( View Tweet )
1 year 6 months ago
UK study of pneumococcal vaccination in UK, shows IMID pts had suboptimal vax against pneumococcus. In 32 277 pts (RA 14151, IBD 13631, SpA 3804, SLE 691) saw 57% vaccinated; lower if <45 yrs (32%), IBD (42%). Vax not associated w/ IMID flare https://t.co/y5JHYaEpA9 https://t.co/zUXfDoqyal
Dr. John Cush @RheumNow ( View Tweet )
1 year 6 months ago
From LG cohort of myeloid neoplasms (861 MDS, 640 AML, 112 MDS/MPN, 89 MPN) autoimmune Rheum Dz (AIRD) found in 7.7% (lit suggests 8-30%), less in AML (4.7% vs 9.5% others). Common: RA (42%), CTD(18%), PMR (14%), vasculitis (12%), AxSpA (7%). https://t.co/ZXxOrZBunZ https://t.co/m5nIgrhohw
Dr. John Cush @RheumNow ( View Tweet )
1 year 6 months ago
SLE Topic Panel: EULAR 2024 Dr.Jack Cush moderates this topic panel on SLE with Drs. Yuz Yusof and Andrea Fava. https://t.co/nBTiIeGd99 https://t.co/5BK72vbR5V
Dr. John Cush @RheumNow ( View Tweet )
1 year 6 months ago
Australian Womens survey, from 25 467 responders the prevalence of #RA varies by how defined - 3·9% for self-reported RA, 1·9% based on the medication dispensed, and 0·5% by self-reported medication use definitions. https://t.co/2FUwftajlG https://t.co/4a5CIfw8hS
Dr. John Cush @RheumNow ( View Tweet )
1 year 6 months ago
3 yr German laboratory study of 71,597 laboratory tests, found 238 positive tests for 13 myositis autoAbs in 209 patients. Pos. results due to Idiopathic inflammatory myopathy in 37(18%), other inflammatory rheum Dz 90 (43%) or NO Rheum Dx 82 (39%) https://t.co/KKg0X1AyU1 https://t.co/FfVfufaUm4
Dr. John Cush @RheumNow ( View Tweet )
1 year 6 months ago
JAK Inhibitors Reduce Macular Degeneration Insurance claims data showed that patients with autoimmune disorders who took JAK inhibitors had lower rates of AMD, hinting that the drugs might treat the common eye disease. https://t.co/bx0UCp0o3r https://t.co/FXSlcFHYXI
Dr. John Cush @RheumNow ( View Tweet )
1 year 6 months ago
Geography of Arthritis-attributable Pain in the USA The journal Pain highlights geographic differences in arthritis pain and outcomes, mainly in the Deep South and Appalachia. Severe arthritis pain is more prevalent in the SW, PNW, GA, FL, and ME regions. https://t.co/e4VuUDWoQt https://t.co/onHbLjAyHx
Dr. John Cush @RheumNow ( View Tweet )
1 year 6 months ago
JAMA Patient Education Handout on Polymyalgia Rheumatica (PMR) https://t.co/J1rpcRltM3 https://t.co/gEUcbE1FuP
Dr. John Cush @RheumNow ( View Tweet )
1 year 6 months ago
Updated EULAR Recommendations on the Treatment of Systemic Sclerosis Medscape has published an overview to the 2024 updated recommendations for the treatment of SSc presented in Vienna at EULAR 2024. https://t.co/rmBIfNzJcu https://t.co/uZ2JUdsecZ
Dr. John Cush @RheumNow ( View Tweet )
1 year 6 months ago
Retrospective study, biopsy-proven Lupus Nephritis pts - 35 of 115 pts (30%) were ANCA positive. ANCA+ LN pts had higher dz activity, predominantly proliferative LN, require more immunosuppressives (CTX, MMF) to achieve remission. https://t.co/jzU8fPYHps https://t.co/E7pMDWJmKt
Dr. John Cush @RheumNow ( View Tweet )
1 year 6 months ago
Systemic sclerosis sine scleroderma Systemic sclerosis sine scleroderma (ssSSc), which accounts for nearly 10% of systemic sclerosis (SSc) patients and was first described in 1962, is a subset of SSc. https://t.co/5NMykTHEtK https://t.co/JNo27zaTrJ
Dr. John Cush @RheumNow ( View Tweet )
1 year 6 months ago
×